The influence of A1AR on tau pathogenesis was examined using known adenosine receptor agonists and antagonists and the results revealed that inhibition of adenosine receptor signaling can effectively suppress AD-tau-seeded neuronal tau pathology and reduce the internalization of pathogenic tau seeds, similar to the downregulation of MSUT2. Here, MAPT is linked to Alzheimer disease.